Skip to content

Xtant Medical Holdings XTNT Additional Paid-In Capital

Additional Paid-In Capital at other companies

Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$820.25M+4.3%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$10.2B+1.1%
Globus Medical logo
Globus MedicalGMED
$3.21B+5.0%
Alphatec Holdings logo
Alphatec HoldingsATEC
$1.48B+15.7%
SI-BONE, Inc. logo
SI-BONE, Inc.SIBN
$633.03M+4.7%
Medtronic logo
MedtronicMDT
$20.93B+0.4%

Other financials

Income statement

See full
Revenue$20.9M-36.5%
Gross profit$12.0M-40.9%
Operating income-$2.9M-375%
Net income-$3.1M-5,426%
EPS (diluted)-$0.02

Balance sheet

See full
Cash & equivalents$12.2M+124%
Total debt$15.0M-34.9%
Total equity$48.6M+10.8%
Total assets$78.0M-18.6%

Cash flow

See full
Operating cash flow-$2.1M-265%
CapEx$194.0K-83.7%
Free cash flow-$2.3M-2,753%

Valuation

See full
Market cap$59.05M-32.5%
Enterprise value$61.89M-41.5%
P/E32.3×
P/S0.5×-0.2×

Profitability

See full
Gross margin62.3%+4.2pp
Operating margin4.8%+2.8pp
Net margin1.5%+0.8pp
FCF margin6.4%+4.1pp

Returns & leverage

See full
Return on equity3.9%+2.1pp
Debt / equity0.3×-0.2×
Current ratio3.3×+1.0×

Where this comes from

Reported directly by Xtant Medical Holdings in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapital.

The official record: Xtant Medical Holdings’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xtant Medical Holdings's additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Xtant Medical Holdings's additional paid-in capital?
Xtant Medical Holdings (XTNT) reported additional paid-in capital of $306.18M in Q1 2026.
How has Xtant Medical Holdings's additional paid-in capital changed year-over-year?
Xtant Medical Holdings's additional paid-in capital increased by 0.9% year-over-year, from $303.49M to $306.18M.
What is the long-term trend for Xtant Medical Holdings's additional paid-in capital?
Over 5 years (2020 to 2025), Xtant Medical Holdings's additional paid-in capital has grown at a 4.5% compound annual growth rate (CAGR), from $244.85M to $305.44M.
What does additional paid-in capital mean?
Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.